Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Successful treatment of primary refractory anemia with a combination regimen of all-trans retinoic acid, calcitriol, and androgen.

Zhang W, Zhou F, Cao X, Cheng Y, He A, Liu J, Ma X, Chen G.

Leuk Res. 2006 Aug;30(8):935-42. Epub 2006 Jan 30.

PMID:
16445979
[PubMed - indexed for MEDLINE]
2.

[Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen].

Zhou FL, Zhang WG, Cao XM, Chen YX, He AL, Liu J, Zhao WH, Ma XR, Chen G.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):861-6. Chinese.

PMID:
16277859
[PubMed - indexed for MEDLINE]
3.

[Low dose all-trans retinoic acid and androgen therapy for patients with myelodysplastic syndrome].

Guan M, Chen SC, Li RS, Ge CW, Zhu HL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Dec;12(6):774-8. Chinese.

PMID:
15631659
[PubMed - indexed for MEDLINE]
4.

[Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases].

Guan M, Chen SC, Ge CW.

Zhonghua Yi Xue Za Zhi. 2009 Apr 7;89(13):919-22. Chinese.

PMID:
19671296
[PubMed - indexed for MEDLINE]
5.

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.

Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, Romanski A, Kramer OH, Kampfmann M, Hoelzer D, Neubauer A, Ruthardt M, Ottmann OG.

Cancer. 2005 Dec 15;104(12):2717-25.

PMID:
16294345
[PubMed - indexed for MEDLINE]
Free Article
6.

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.

Morris MJ, Smaletz O, Solit D, Kelly WK, Slovin S, Flombaum C, Curley T, Delacruz A, Schwartz L, Fleisher M, Zhu A, Diani M, Fallon M, Scher HI.

Cancer. 2004 May 1;100(9):1868-75.

PMID:
15112267
[PubMed - indexed for MEDLINE]
Free Article
7.

[Cyclosporine A based therapy for myelodysplastic syndrome].

Li ZL, Gong M, Xu SH, Huang FZ, Chen YR, Ma YG.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):867-70. Chinese.

PMID:
16277860
[PubMed - indexed for MEDLINE]
8.

Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS.

Cancer. 2006 May 15;106(10):2136-42.

PMID:
16598750
[PubMed - indexed for MEDLINE]
Free Article
9.

Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome.

Soriano AO, Yang H, Faderl S, Estrov Z, Giles F, Ravandi F, Cortes J, Wierda WG, Ouzounian S, Quezada A, Pierce S, Estey EH, Issa JP, Kantarjian HM, Garcia-Manero G.

Blood. 2007 Oct 1;110(7):2302-8. Epub 2007 Jun 27.

PMID:
17596541
[PubMed - indexed for MEDLINE]
Free Article
10.

A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma.

Khan KD, Emmanouilides C, Benson DM Jr, Hurst D, Garcia P, Michelson G, Milan S, Ferketich AK, Piro L, Leonard JP, Porcu P, Eisenbeis CF, Banks AL, Chen L, Byrd JC, Caligiuri MA.

Clin Cancer Res. 2006 Dec 1;12(23):7046-53.

PMID:
17145827
[PubMed - indexed for MEDLINE]
Free Article
11.

A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.

Adamson PC, Matthay KK, O'Brien M, Reaman GH, Sato JK, Balis FM.

Pediatr Blood Cancer. 2007 Oct 15;49(5):661-5.

PMID:
16900483
[PubMed - indexed for MEDLINE]
12.

High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.

Buckstein R, Kerbel RS, Shaked Y, Nayar R, Foden C, Turner R, Lee CR, Taylor D, Zhang L, Man S, Baruchel S, Stempak D, Bertolini F, Crump M.

Clin Cancer Res. 2006 Sep 1;12(17):5190-8.

PMID:
16951238
[PubMed - indexed for MEDLINE]
Free Article
13.

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.

Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Holló P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J.

Br J Dermatol. 2008 Apr;158(4):808-17. doi: 10.1111/j.1365-2133.2008.08487.x. Epub 2008 Feb 21.

PMID:
18294310
[PubMed - indexed for MEDLINE]
14.

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.

Clin Ther. 2008 Jun;30(6):1102-12. doi: 10.1016/j.clinthera.2008.06.013.

PMID:
18640466
[PubMed - indexed for MEDLINE]
15.

Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromes.

Ferrero D, Darbesio A, Giai V, Genuardi M, Dellacasa CM, Sorasio R, Bertini M, Boccadoro M.

Br J Haematol. 2009 Feb;144(3):342-9. doi: 10.1111/j.1365-2141.2008.07465.x. Epub 2008 Nov 19.

PMID:
19036104
[PubMed - indexed for MEDLINE]
16.

Androgen in the treatment of refractory anemia.

Kobaba R, Kanamaru A, Takemoto Y, Kohsaki M, Kakishita E, Nagai K.

Int J Hematol. 1991 Apr;54(2):103-7.

PMID:
1747444
[PubMed - indexed for MEDLINE]
17.

Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.

Sacchi S, Pozzi S, Marcheselli R, Federico M, Tucci A, Merli F, Orsucci L, Liberati M, Vallisa D, Brugiatelli M; Italian Lymphoma Study Group.

Cancer. 2007 Jul 1;110(1):121-8.

PMID:
17503433
[PubMed - indexed for MEDLINE]
Free Article
18.

Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.

Boorjian SA, Milowsky MI, Kaplan J, Albert M, Cobham MV, Coll DM, Mongan NP, Shelton G, Petrylak D, Gudas LJ, Nanus DM.

J Immunother. 2007 Sep;30(6):655-62.

PMID:
17667529
[PubMed - indexed for MEDLINE]
19.

Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.

Inada S, Tomidokoro T, Fukunari H, Sato T, Hatano T, Nishimura A, Kawauchi Y, Nikkuni K, Shimizu T, Sato T, Yanagi M, Takahashi S, Yoshida H, Sugita M, Hayashi T.

Cancer Chemother Pharmacol. 2009 Jan;63(2):267-73. doi: 10.1007/s00280-008-0736-4. Epub 2008 Apr 1.

PMID:
18379784
[PubMed - indexed for MEDLINE]
20.

[Multiple discriminant analysis for prognosis of refractory anemia].

Kobaba R, Kousaki M, Andou S, Okuda K, Tamura A, Miyazaki E, Inoue N, Okamoto T, Takemoto Y, Kanamaru A, et al.

Rinsho Ketsueki. 1991 Aug;32(8):815-21. Japanese.

PMID:
1942520
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk